New blood thinner 'antidote' to help doctors move past warfarin

NEW YORK, Dec 23 (Reuters) - A new class of blood thinners that competes with widely used warfarin should get a boost next year when an "antidote" that can reverse the medications' effects in an emergency is expected to enter the market, according to top U.S. heart doctors and investors.